| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $136.2M | +81.6% |
| Cost of Revenue | $65.1M | +71.7% |
| Gross Profit | $71.0M | +91.6% |
| R&D Expense | $48.4M | +67.2% |
| SG&A Expense | $131.8M | +48.3% |
| Operating Income | -$109.2M | -35.2% |
| Interest Expense | $4.0M | -22.9% |
| Income Tax | $0 | — |
| Net Income | -$105.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $257.2M | +15.9% |
| Accounts Receivable | $48.4M | +216.8% |
| Inventory | $39.8M | +39.3% |
| Current Assets | $350.6M | +28.6% |
| Total Assets | $404.7M | +30.8% |
| Current Liabilities | $45.9M | +30.1% |
| Long-term Debt | $51.3M | +0.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$108.0M | -34.4% |
| Capital Expenditures | $25.2M | +850.1% |
| Investing Cash Flow | -$25.2M | -850.1% |
| Financing Cash Flow | $167.8M | +4545.5% |
| Free Cash Flow | -$133.2M | -60.4% |
| -21.5% |
| EPS (Basic) | -$2.24 | -14.3% |
| EPS (Diluted) | -$2.24 | -14.3% |
| Total Liabilities |
| $124.0M |
| +10.4% |
| Stockholders' Equity | $280.8M | +42.5% |